The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
High-throughput functional genomics using CRISPR-Cas9
Open accessAbstract
Forward genetic screens are powerful tools for the discovery and functional annotation of genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas9 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening. In this Review, we describe recent advances using Cas9 for genome-scale screens, including knockout approaches that inactivate genomic loci and strategies that modulate transcriptional activity. We discuss practical aspects of screen design, provide comparisons with RNA interference (RNAi) screening, and outline future applications and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the deficiencies of RNAi-based methods in the areas of reagent fidelity and scalability make it difficult to use this approach to accurately map drug target interactions across a large matrix of cell lines and drug treatments”
From A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution (2017) · cites this paper as Shalem et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“This has limited pooled screens largely to vetting genes for their potential impact on cell fitness”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Shalem et al., 2015
In the citing paper
“So far three distinct bacterial CRISPR systems have been identified; Type I, II and III, and it is the Type II system that has mainly been adapted for use in artificial gene regulation and genome editing (Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
In the citing paper
“The most commonly used CRISPR Type II system consists of a gRNA and an endonuclease, the CRISPR-associated (Cas) nuclease, Cas9, which cleaves the targeted chromosomal DNA in a site-specific manner triggering endogenous DNA repair systems resulting in genome modification (for an in-depth review, see Doudna and Charpentier 2014; Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Hosseini-Kharat, M., Bremmell, K. E., Grubor‐Bauk, B., & Prestidge, C. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.002 · Cited by 37
Functional Genomic Strategies for Elucidating Human–Virus Interactions
Perreira, J. M., Meraner, P., & Brass, A. L. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2015.11.001 · Cited by 39
CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions
Gebre, M. S., Nomburg, J., & Gewurz, B. E. (2018) · Viruses · doi:10.3390/v10020055 · Cited by 37
Li, S., Li, M., Liu, X., Yang, Y., Wei, Y., Chen, Y., Qiu, Y., Zhou, T., Feng, Z., Ma, D., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.05.001 · Cited by 36
Guide-target mismatch effects on dCas9–sgRNA binding activity in living bacterial cells
Feng, H., Guo, J., Wang, T., Zhang, C., & Xing, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1295 · Cited by 38
Niazian, M., Belzile, F. J., & Torkamaneh, D. (2022) · Plants · doi:10.3390/plants11081044 · Cited by 36
Bian, S., Zhou, Y., Hu, Y., Cheng, J., Chen, X., Xu, Y., & Liu, P. (2017) · Scientific Reports · doi:10.1038/srep42512 · Cited by 36
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
Martinez-Martín, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/2197615 · Cited by 36
Deciphering evolutionary dynamics of SWEET genes in diverse plant lineages
Li, X., Si, W., Qin, Q., Wu, H., & Jiang, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-31589-x · Cited by 35
Tong, Z., Sathe, A., Ebner, B., Pan, Q., Veltkamp, C., Gschwend, J. E., Holm, P. S., & Nawroth, R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1322-9 · Cited by 36
New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells
Bassaganyas, L., Popa, S. J., Horlbeck, M. A., Puri, C., Stewart, S. E., Campelo, F., Ashok, A., Butnaru, C. M., Brouwers, N., Heydari, K., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201902028 · Cited by 36
A high-performance genetically encoded fluorescent biosensor for imaging physiological peroxynitrite
Chen, Z., Zhang, S., Li, X., & Ai, H. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.013 · Cited by 35
Targeted genetic screening in bacteria with a Cas12k-guided transposase
Chen, W., Ren, Z.-H., Tang, N., Chai, G., Zhang, H., Zhang, Y., Ma, J., Wu, Z., Shen, X., Huang, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109635 · Cited by 35
Kuiper, B. P., Prins, R. C., & Billerbeck, S. (2021) · ChemBioChem · doi:10.1002/cbic.202100507 · Cited by 36
Direct and indirect approaches to identify drug modes of action
Tulloch, L. B., Menzies, S. K., Coron, R. P., Roberts, M. D., Florence, G. J., & Smith, T. (2017) · IUBMB Life · doi:10.1002/iub.1697 · Cited by 36
Zheng, C., Wei, Y., Zhang, P., Lin, K., He, D., Teng, H., Manyam, G. C., Zhang, Z., Liu, W., Lee, H. R. L., et al. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01117-1 · Cited by 36
Gwiazda, K., Grier, A. E., Sahni, J., Burleigh, S. M., Martin, U., Yang, J., Popp, N. A., Krutein, M. C., Khan, I., Jacoby, K., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.105 · Cited by 35
Advances and perspectives in the application of CRISPR/Cas9 in insects.
Chen, L., Wang, G., Zhu, Y., Xiang, H., & Wang, W. (2016) · PubMed · doi:10.13918/j.issn.2095-8137.2016.4.220 · Cited by 34
CRISPR/Cas9-mediated mutagenesis of homologous genes in Chinese kale
Sun, B., Zheng, A., Jiang, M., Xue, S., Yuan, Q., Jiang, L., Chen, Q., Li, M., Wang, Y., Zhang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34884-9 · Cited by 34
Self-citationZhang, Y., Feng, J., Wang, P., Xia, J., Li, X., & Zou, X. (2019) · Gene · doi:10.1016/j.gene.2019.04.079 · Cited by 34
Alternative splicing programming of axon formation
Zheng, S. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1585 · Cited by 36
Lian, B., Pei, Y., Jiang, Y., Xue, M., Li, D., Li, X., Zheng, Y.-Z., Liu, X.-Y., Qiao, F., Sun, W.-L., et al. (2020) · Theranostics · doi:10.7150/thno.44997 · Cited by 34
On the role of p53 in the cellular response to aneuploidy
Narkar, A., Johnson, B. A., Bharne, P., Zhu, J., Padmanaban, V., Biswas, D., Fraser, A. K., Iglesias, P. A., Ewald, A. J., & Li, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108892 · Cited by 34
Kcam, M. C. V., Tsong, A. J., & Chappell, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab211 · Cited by 36
Nie, M., Du, L., Ren, W., Joung, J., Ye, X., Shi, X., Ciftci, S., Liu, D., Wu, K., Zhang, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03695-8 · Cited by 35
Self-citationDias, G. B., Altammami, M. A., El‐Shafie, H. A. F., Alhoshani, F. M., Al‐Fageeh, M. B., Bergman, C., & Manee, M. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89091-w · Cited by 35
CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
Serajian, S., Ahmadpour, E., Oliveira, S. M. R., Pereira, M. D. L., & Heidarzadeh, S. (2021) · Pharmaceuticals · doi:10.3390/ph14111171 · Cited by 35
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 36
Gohl, D. M., Magli, A., Garbe, J., Becker, A., Johnson, D. M., Anderson, S., Auch, B., Billstein, B., Froehling, E., McDevitt, S. L., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1691-6 · Cited by 35
Transcriptional Enhancers: Bridging the Genome and PhenomePreprint
Ren, B., & Yue, F. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027219 · Cited by 34
Genome-scale CRISPRi screening: A powerful tool in engineering microbiology
Sun, L., Zheng, P., Sun, J., Wendisch, V. F., & Wang, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100089 · Cited by 35
Yin, Y., Wen, J., Wen, M., Fu, X., Ke, G., & Zhang, X. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115839 · Cited by 33
Khan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 37
Henser‐Brownhill, T., Monserrat, J., & Scaffidi, P. (2017) · Epigenetics · doi:10.1080/15592294.2017.1395121 · Cited by 33
Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.
Savell, K. E., & Day, J. J. (2017) · PubMed · Cited by 33
Mondal, S., Halder, S. K., & Mondal, K. C. (2021) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-021-00045-9 · Cited by 33
Protein Moonlighting Revealed by Noncatalytic Phenotypes of Yeast Enzymes
Espinosa‐Cantú, A., Ascencio, D., Herrera-Basurto, M. S., Xu, J., Roguev, A., Krogan, N. J., & DeLuna, A. (2017) · Genetics · doi:10.1534/genetics.117.300377 · Cited by 34
Eisenhut, P., Marx, N., Borsi, G., Papež, M., Ruggeri, C., Baumann, M., & Borth, N. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.11.003 · Cited by 33
GWAS as a Driver of Gene Discovery in Cardiometabolic Diseases
Atanasovska, B., Kumar, V., Fu, J., Wijmenga, C., & Hofker, M. H. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.10.004 · Cited by 32
Human stem cell-based disease modeling: prospects and challenges
Johnson, J. Z., & Hockemeyer, D. F. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.007 · Cited by 33
A genome editing primer for the hematologist
Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32
Big Data Approaches for Modeling Response and Resistance to Cancer Drugs
Jiang, P., Sellers, W. R., & Liu, X. S. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013350 · Cited by 32
Takai, A., Dang, H. T., Oishi, N., Khatib, S. A., Martin, S. P., Dominguez, D. A., Luo, J., Bagni, R., Wu, X., Powell, K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3015 · Cited by 32
CRISPulator: a discrete simulation tool for pooled genetic screens
Nagy, T. L., & Kampmann, M. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1759-9 · Cited by 32
Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review
Ebrahimi, V., & Hashemi, A. (2020) · Gene · doi:10.1016/j.gene.2020.144813 · Cited by 32
Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia
Dobrindt, K., Zhang, H., Das, D., Abdollahi, S., Prorok, T., Ghosh, S. D., Weintraub, S. J., Genovese, G., Powell, S. K., Lund, A. N., et al. (2020) · Complex Psychiatry · doi:10.1159/000512716 · Cited by 32
Techniques for investigating lncRNA transcript functions in neurodevelopment
Srinivas, T., Soares, E. S., & Guil, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02377-5 · Cited by 37
Identifying synthetic lethal targets using CRISPR/Cas9 system
Dhanjal, J. K., Radhakrishnan, N., & Sundar, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.07.007 · Cited by 32
A permutation-based non-parametric analysis of CRISPR screen data
Jia, G., Wang, X., & Xiao, G. (2017) · BMC Genomics · doi:10.1186/s12864-017-3938-5 · Cited by 32
Akıncı, E., Cha, M., Lin, L., Yeo, G. H. T., Hamilton, M. C., Donahue, C. J., Bermudez-Cabrera, H. C., Zanetti, L. C., Chen, M., Barkal, S. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.27.270819 · Cited by 32
Genome-scale CRISPR screening for modifiers of cellular LDL uptake
Emmer, B. T., Sherman, E. J., Lascuna, P. J., Graham, S. E., Willer, C. J., & Ginsburg, D. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009285 · Cited by 32
CRISPRi functional genomics in bacteria and its application to medical and industrial research
Enright, A. L., Heelan, W. J., Ward, R. D., & Peters, J. M. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00170-22 · Cited by 32
Prioritising Causal Genes at Type 2 Diabetes Risk Loci
Grotz, A. K., Gloyn, A. L., & Thomsen, S. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0907-y · Cited by 32
Anderson, D. E., Pfeffermann, K., Kim, S. Y., Sawatsky, B., Pearson, J. L., Kovtun, M., Corcoran, D. L., Krebs, Y., Sigmundsson, K., Jamison, S. F., et al. (2019) · mBio · doi:10.1128/mbio.00826-19 · Cited by 31
Wang, S., Crisman, L., Miller, J. L., Datta, I., Gulbranson, D. R., Tian, Y., Yin, Q., Yu, H., & Shen, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010821 · Cited by 31
Nakamura, M., Okamura, Y., & Iwai, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-55302-8 · Cited by 31
Heme-Dependent Supramolecular Nanocatalysts: A Review
Liu, Y., & Wang, Z. (2023) · ACS Nano · doi:10.1021/acsnano.2c11894 · Cited by 31
Synthetic chimeric nucleases function for efficient genome editing
Liu, R., Liang, L., Freed, E. F., Chang, H., Oh, E. J., Liu, Z., Garst, A. D., Eckert, C. A., & Gill, R. T. (2019) · Nature Communications · doi:10.1038/s41467-019-13500-y · Cited by 33
Genome-scale identification of cellular pathways required for cell surface recognitionPreprint
Sharma, S., Scott, J. B., Couch, A. C. M., Yusa, K., & Wright, G. J. (2018) · Genome Research · doi:10.1101/gr.231183.117 · Cited by 31
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Zhou, S., Li, Y., Wu, Q., & Gong, C. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70 · Cited by 30
Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain
Walters, B. J., Azam, A. B., Gillon, C. J., Josselyn, S. A., & Zovkic, I. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2015.00362 · Cited by 31
Can the Lateral Habenula Crack the Serotonin Code?
Tchenio, A., Valentinova, K., & Mameli, M. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00034 · Cited by 33
Crosstalk between transcription and metabolism: how much enzyme is enough for a cell?
Donati, S., Sander, T., & Link, H. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1396 · Cited by 34
A genome-wide comprehensive analysis of alterations in driver genes in non-small-cell lung cancer
Yi, J., Xiang, W., Li, X., Wan, L., Dong, J., & Wang, R. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000571 · Cited by 30
High-throughput methods for genome editing: the more the better
Huang, Y., Shang, M., Liu, T., & Wang, K. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac017 · Cited by 32
Deng, L., Li, Y., Zhu, S., Li, M., Wang, Y., Cao, X., Wang, Q., & Guo, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01315-2 · Cited by 30
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 32
Lessons from reverse-genetic studies of lncRNAs
Nakagawa, S. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.011 · Cited by 32
Araldi, R. P., Khalil, C., Grignet, P. H., Teixeira, M. R., de Melo, T. C., Módolo, D. G., Fernandes, L. G. V., Ruiz, J. L. M., & de Souza, E. B. (2020) · Gene · doi:10.1016/j.gene.2020.144636 · Cited by 33
Candida glabrata : new tools and technologies—expanding the toolkit
Ho, H.-L., & Haynes, K. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov066 · Cited by 29
Kennedy, P. H., Sheikh, A. A. D., Balakar, M., Jones, A. C., Olive, M. E., Hegde, M., Matias, M. I., Pirete, N., Burt, R. A., Levy, J. M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02256-z · Cited by 30
Advancements in CRISPR/Cas9 technology—Focusing on cancer therapeutics and beyond
Mirza, Z., & Karim, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.026 · Cited by 29
Voigt, O., Knabe, N., Nitsche, S., Erdmann, E. A., Schumacher, J., & Gorbushina, A. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-79120-5 · Cited by 29
Lenoir, W. F., Morgado, M. C., DeWeirdt, P. C., McLaughlin, M. E., Griffith, A. L., Sangree, A. K., Feeley, M. N., Anvar, N. E., Kim, E., Bertolet, L. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26867-8 · Cited by 31
Pooled genetic screens with image‐based profiling
Walton, R. T., Singh, A. K., & Blainey, P. C. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110768 · Cited by 29
Active learning for optimal intervention design in causal models
Zhang, J., Cammarata, L. V., Squires, C., Sapsis, T. P., & Uhler, C. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00719-0 · Cited by 29
Interplay Between Genetic and Epigenetic Mechanisms in Rheumatoid Arthritis
Frank‐Bertoncelj, M., Klein, K., & Gay, S. (2017) · Epigenomics · doi:10.2217/epi-2016-0142 · Cited by 29
CRISPRcloud: a secure cloud-based pipeline for CRISPR pooled screen deconvolution
Jeong, H.-H., Kim, S., Rousseaux, M. W. C., Zoghbi, H. Y., & Liu, Z. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx335 · Cited by 29
Hoffman, T., Antovski, P., Tebon, P. J., Xu, C., Ashammakhi, N. A., Ahadian, S., Morsut, L., & Khademhosseini, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909882 · Cited by 32
CRISPR: A new paradigm of theranostics
Yadav, N., Narang, J., Chhillar, A. K., & Rana, J. S. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102350 · Cited by 31
Sheridan, R. M., & Bentley, D. L. (2016) · BioTechniques · doi:10.2144/000114378 · Cited by 28
Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research
Galuschka, C., Proynova, R., Roth, B., Augustin, H. G., & Müller‐Decker, K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3099 · Cited by 28
Acosta, S., Fiore, L., Carota, I. A., & Oliver, G. C. (2018) · genesis · doi:10.1002/dvg.23212 · Cited by 28
Campos, T. D. L., Korhonen, P. K., Hofmann, A., Gasser, R. B., & Young, N. D. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107822 · Cited by 28
Yan, M., Zheng, D., Li, S., Ding, X.-Y., Wang, C., Guo, X.-P., Zhan, L., Jin, Q., Yang, J., & Sun, Y. (2022) · Science Advances · doi:10.1126/sciadv.add5907 · Cited by 28
Targeted genome regulation via synthetic programmable transcriptional regulators
Piatek, A., & Mahfouz, M. M. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2016.1165180 · Cited by 28
The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9
Tsui, T. K. M., Hand, T. H., Duboy, E. C., & Li, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00050 · Cited by 28
Targeted RNA Knockdown by a Type III CRISPR-Cas Complex in Zebrafish
Fricke, T., Smalakytė, D., Łapiński, M., Pateria, A., Weige, C. C., Pástor, M., Kolano, A., Winata, C. L., Šikšnys, V., Tamulaitis, G., et al. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0032 · Cited by 29
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
Gautron, A., Bachelot, L., Aubry, M., Leclerc, D., Quéméner, A. M., Corre, S., Rambow, F., Paris, A., Tardif, N., Leclair, H. M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013466 · Cited by 32
Park, J., & Bae, S. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx695 · Cited by 28
Sun, X., Zhang, H., Jia, Y., Li, J., & Jia, M. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100154 · Cited by 27
Gao, H., Pei, X., Song, X., Wang, S., Yang, Z., Zhu, J., Lin, Q., Zhu, Q., & Yang, X. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1477894 · Cited by 27
Biotechnological production of sweeteners
Hernández-Pérez, A. F., Jofre, F. M., Queiroz, S. D. S., de Arruda, P. V., Chandel, A. K., & Felipe, M. D. G. D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64323-0.00009-6 · Cited by 27
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Liu, J., Sun, M., Cho, K. B., Gao, X., & Guo, B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105304 · Cited by 28
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment
Liu, J., Hideshima, T., Xing, L., Wang, S., Zhou, W., Samur, M., Sewastianik, T., Ogiya, D., An, G., Gao, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg2697 · Cited by 27
Wei, W., Li, Y., Wang, C., Gao, S., Zhao, Y., Yang, Z., Wang, H., Gao, Z., Jiang, Y., He, Y., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106285 · Cited by 27
Simultaneous multi-site editing of individual genomes using retron arrays
González-Delgado, A., Lopez, S. C., Rojas-Montero, M., Fishman, C. B., & Shipman, S. L. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01665-7 · Cited by 27
Panchision, D. M. (2016) · Stem Cells · doi:10.1002/stem.2295 · Cited by 27
Decoding the noncoding genome via large-scale CRISPR screens
Shukla, A., & Huangfu, D. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.001 · Cited by 27
Le, B. D., & Stein, J. L. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12839 · Cited by 30
Metadata
- Authors
- Shalem, O., Sanjana, N. E., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Shalem, Ophir
- Zhang, Feng
- Venue
- Nature Reviews Genetics
- Published
- 2015-04-09
- Volume
- 16
- Issue
- 5
- Pages
- 299-311
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC4503232
- OpenAlex
- W2026592619
- Cited by
- 1,233
- References
- 130
- Citations by year
- 2026: 71 · 2025: 91 · 2024: 103 · 2023: 85 · 2022: 101 · 2021: 105 · 2020: 121 · 2019: 117 · 2018: 131 · 2017: 145 · 2016: 123 · 2015: 37
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Klarman Family Foundation
- Simons Center for the Social Brain, Massachusetts Institute of Technology
- National Institute of Mental Health (DP1MH100706)
- National Human Genome Research Institute (K99HG008171)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, genome-wide screen, guide RNA library, forward genetic screen, gene knockout, transcriptional regulation, phenotypic screening, screen design, functional genomics
- MeSH terms
- Animals, Genetic Testing, Humans, Models, Genetic, Gene Library, Genomics, RNA Interference, Mice, Gene Knockout Techniques, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review